📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Persistent Launches AI-Powered Drug Discovery Solution with NVIDIA Collaboration
Persistent Systems has announced a strategic collaboration with NVIDIA to launch the Generative Molecules and Virtual Screening (GenMolVS) solution for the Healthcare and Life Sciences industry. This solution leverages the NVIDIA BioNeMo framework to accelerate computational drug discovery, potentially reducing experimental cycles from months to days. By integrating NVIDIA's full-stack AI platform and accelerated computing, Persistent aims to provide production-grade Agentic AI applications for BioPharma clients. This move strengthens Persistent's position in the high-growth AI-led digital engineering market, supported by its global workforce of over 26,500 employees.
Key Highlights
Collaboration utilizes NVIDIA BioNeMo and NeMo Agent Toolkit for high-fidelity molecular simulation.
The GenMolVS solution aims to reduce drug discovery timelines from several months to just a few days.
Persistent will leverage NVIDIA AI Enterprise and accelerated compute for cost-effective, production-grade scaling.
The company has seen a 468% growth in brand value since 2020, according to Brand Finance India 100.
💼 Action for Investors
Investors should monitor the Healthcare and Life Sciences vertical for increased revenue contribution and high-margin AI project wins following this NVIDIA partnership. This collaboration positions Persistent as a key player in the specialized Generative AI space for drug discovery.
CARE Reaffirms 'AA-; Stable' Rating for Medi Assist Subsidiary; Market Share Hits 21.3%
CARE Ratings has reaffirmed the 'CARE AA-; Stable' rating for Medi Assist's key subsidiary, MAITPA, following its ₹412 crore acquisition of Paramount TPA. The company successfully repaid its ₹150 crore bridge debt by January 2026, returning to a nil external debt position. While the group insurance market share has surged to 32.2%, operating margins have moderated to 13.67% due to higher software fees and integration costs. Total Premiums Under Management (PUM) are projected to reach ₹26,500 crore in FY26, reflecting strong inorganic growth.
Key Highlights
CARE reaffirmed 'AA-; Stable' and 'A1+' ratings for bank facilities totaling ₹266 crore.
Market share in the TPA industry reached 21.3% overall and 32.2% in the group segment post-acquisition.
Successfully repaid ₹150 crore bridge debt used for the Paramount TPA acquisition as of January 15, 2026.
Premiums Under Management (PUM) expected to grow to ₹26,500 crore in FY26 from ₹21,108 crore in FY25.
Operating margins moderated to 13.67% in FY25, with a recovery target of 12-13% in the medium term.
💼 Action for Investors
The rating reaffirmation validates the company's financial discipline in managing large acquisitions without stretching the balance sheet. Investors should monitor the realization of synergy benefits from the Paramount TPA integration to see if margins return to historical levels.
Persistent Systems Reaffirmed [ICRA] AA+ (Stable) Credit Rating
ICRA Limited has reaffirmed the issuer rating of Persistent Systems Limited at [ICRA] AA+ with a Stable outlook. This reaffirmation, dated March 5, 2026, follows the previous rating assigned in January 2025. The AA+ rating indicates a very high degree of safety regarding the timely servicing of financial obligations and very low credit risk. This reflects the company's sustained financial health and strong position in the IT services sector.
Key Highlights
ICRA reaffirmed the Issuer Rating of [ICRA] AA+ for Persistent Systems Limited.
The outlook on the credit rating has been maintained as Stable.
The rating was originally assigned on January 21, 2025, and successfully reaffirmed on March 5, 2026.
The AA+ rating signifies very low credit risk and a strong capacity to meet financial commitments.
💼 Action for Investors
The reaffirmation of a high credit rating confirms the company's financial stability and low-risk profile. Long-term investors can remain confident in the company's balance sheet strength and debt-servicing capabilities.
Persistent Systems Opens Melbourne Innovation Center to Drive AI Adoption in ANZ
Persistent Systems has launched a new Innovation Center in Melbourne, Australia, to accelerate AI-led modernization and digital engineering for the ANZ market. This strategic hub aims to support existing partnerships with top ASX-listed companies in sectors like Banking and Telecommunications. The expansion aligns with the company's AI-first strategy and follows a significant 468% growth in brand value since 2020. By establishing a localized engineering presence, Persistent aims to capture the growing demand for enterprise-scale AI deployment in Australia.
Key Highlights
New Melbourne Innovation Center launched to serve the Australia and New Zealand (ANZ) region.
Focuses on AI-driven enterprise reinvention, legacy modernization, and cloud-native refactoring.
Targets top ASX-listed companies across Banking, Manufacturing, and Telecommunications sectors.
Leverages a global workforce of over 26,500 employees across 18 countries.
Supports the company's reported 468% brand value growth since 2020.
💼 Action for Investors
This expansion strengthens Persistent's position in the high-growth AI services market and diversifies its geographic footprint. Investors should monitor for new contract wins from the ANZ region as a result of this localized presence.
Medi Assist Subsidiary Pays INR 4.83 Crore to Conclude GST Search Operation
Medi Assist Healthcare's material subsidiary, Medi Assist TPA, has concluded a GST search operation conducted by the Maharashtra Department of Goods and Services Tax. The company paid a total of INR 4.83 Crores to settle liabilities arising from a supplier's failure to remit taxes and interest on holdback amounts. This payment was made 'without prejudice' to avoid further penalties, allowing the company to pursue legal remedies or recovery later. Management has confirmed that business operations remain unaffected and there is no further material financial impact.
Key Highlights
GST search operation at Mumbai office concluded on March 2, 2026, following its initiation on February 16, 2026.
Total payment of INR 4.83 Crores made covering aggregate unpaid tax and interest liabilities.
Liability triggered by a defaulting supplier's non-remittance of taxes and interest on customer invoice holdbacks.
Payment made without prejudice to the subsidiary's rights to file representations or seek recovery.
Company reports no material impact on operations or other financial activities beyond the stated payment.
💼 Action for Investors
The settlement amount is relatively small compared to the company's scale, and the conclusion of the search removes regulatory uncertainty. Investors should view this as a routine tax compliance resolution with minimal impact on long-term fundamentals.
Persistent Systems Expands Global Footprint with New Subsidiary in China
Persistent Systems Limited has announced the establishment of a Wholly Owned Foreign Enterprise (WFOE) in China through its Singapore-based subsidiary. The new entity, Baixinteng System Service (Shanghai) Co. Ltd., received its business license from the Shanghai Administration for Market Regulation on February 28, 2026. This strategic move marks the company's formal entry into the Chinese market to bolster its global operations and service delivery. The expansion is part of Persistent's broader strategy to diversify its geographic presence and tap into regional talent and markets.
Key Highlights
Establishment of a Wholly Owned Foreign Enterprise (WFOE) in China on February 27, 2026
Business license received for Baixinteng System Service (Shanghai) Co. Ltd. on February 28, 2026
Expansion facilitated through 100% subsidiary Persistent Systems Pte. Ltd., Singapore
The move aims to strengthen the company's presence and operational capabilities in the Asia-Pacific region
💼 Action for Investors
Investors should view this as a positive step toward geographic diversification and global scale. Monitor upcoming quarterly calls for management's specific revenue and operational targets for the Chinese market.
Medi Assist Expands to Southeast Asia via Strategic AI-Tech Partnership with LawtonAsia
Medi Assist Healthcare Services has entered a strategic partnership with Thailand-based LawtonAsia to deploy its AI-powered health-tech platform in Southeast Asia. This collaboration allows LawtonAsia to use Medi Assist's proprietary systems for medical insurance claims management and flexible benefit plans. The move aligns with Medi Assist's global expansion strategy, leveraging its technology stack to serve international markets. Implementation is currently underway in Thailand, with a full launch expected within the coming weeks.
Key Highlights
Strategic partnership with LawtonAsia to bring AI-driven health-tech to the Thailand market.
Deployment of proprietary platform to streamline claims processing and enhance transparency.
Enables corporate clients to manage flexible benefit plans within insurance programs.
Implementation phase has commenced with a full 'go-live' expected in the coming weeks.
💼 Action for Investors
Investors should monitor the successful execution of this partnership as it demonstrates the scalability of Medi Assist's tech platform beyond India. Positive outcomes could lead to further international contracts and improved margins.
Medi Assist Shareholders Approve Re-appointment of CEO and Chairman for 5-Year Terms
Medi Assist Healthcare Services Limited has announced the successful passage of five key resolutions via postal ballot with overwhelming shareholder support. Dr. Vikram Jit Singh Chhatwal has been re-appointed as Chairman and Whole-Time Director for a five-year term starting March 1, 2026, with 98.64% votes in favor. Similarly, Mr. Satish V N Gidugu was re-appointed as CEO and Whole-Time Director for five years with 99.61% approval. The resolutions also secured the re-appointment of an Independent Director and approved executive remuneration for the next three years.
Key Highlights
Dr. Vikram Jit Singh Chhatwal re-appointed as Chairman and WTD for 5 years with 98.64% votes in favor
Mr. Satish V N Gidugu re-appointed as CEO and WTD for 5 years with 99.61% votes in favor
Dr. Ritu Niraj Anand re-appointed as Independent Director for a second 5-year term with 99.99% approval
Executive remuneration for both the Chairman and CEO approved for a 3-year period effective March 1, 2026
Total of 53,523,094 votes were polled across institutional and non-institutional categories
💼 Action for Investors
Investors should view this as a positive sign of leadership stability and continuity in the company's strategic direction. The high approval ratings indicate strong institutional confidence in the current management team.
Persistent Systems Clarifies No Imminent M&A Transaction Amid Market Speculation
Persistent Systems has issued a formal statement to address recent market rumors regarding potential merger and acquisition activities. The company confirmed that while it continuously evaluates inorganic growth opportunities as part of its strategy, no transaction has reached the stage requiring disclosure under SEBI regulations. This clarification aims to manage investor expectations and reduce volatility caused by unverified reports. The company maintains a governance-oriented approach, promising transparent disclosure if any proposal matures.
Key Highlights
Persistent Systems addresses market speculation regarding potential M&A opportunities
Company states no imminent transaction currently requires disclosure under SEBI Regulation 30
Management confirms that exploring inorganic growth remains a core part of their business strategy
The company emphasizes its commitment to transparent disclosure and governance standards
💼 Action for Investors
Investors should treat recent rumors with caution and rely only on official company disclosures for investment decisions. The stock may see some cooling of speculative interest following this clarification.
GST Department Initiates Search at Medi Assist TPA's Mumbai Office
The Department of Goods and Services Tax, Maharashtra, has initiated a search operation at the Mumbai office of Medi Assist Insurance TPA Private Limited, a material wholly-owned subsidiary of Medi Assist Healthcare Services. The search, conducted under Section 67 of the CGST Act, 2017, commenced on February 16, 2026. While the company claims that business operations remain unaffected and no immediate financial impact is anticipated, the proceedings are currently ongoing. Investors should remain cautious as the final outcome regarding potential tax liabilities or penalties is yet to be determined.
Key Highlights
Search operation initiated by Maharashtra GST Department at the Mumbai office of Medi Assist Insurance TPA Private Limited.
Action taken under Section 67 of the Central Goods and Service Tax Act, 2017, starting February 16, 2026.
The target entity is a material wholly-owned subsidiary of the listed parent company.
Management states that business operations are currently unaffected and no financial impact is expected at this stage.
💼 Action for Investors
Investors should monitor subsequent filings for any quantification of tax demands or penalties resulting from this search. Maintain a watch on the stock as regulatory actions on material subsidiaries can lead to short-term volatility.
Medi Assist Q3 FY26: Consolidated Revenue Up 29.9%, Company Becomes Debt-Free
Medi Assist Healthcare Services reported a robust Q3 FY26 with consolidated total income rising 29.9% YoY, significantly aided by the Paramount acquisition. The company successfully transitioned to a debt-free status in January 2026, having reduced debt from INR 243 crores in September 2025. Operational efficiency improved as Paramount's standalone margins expanded by 557 bps QoQ, while tech-driven fraud prevention (MAven Guard) saved INR 400 crores. The group market share reached a significant 32.2%, reflecting strong organic and inorganic growth.
Key Highlights
Consolidated total income grew 29.9% YoY in Q3 FY26, with 9M FY26 income up 23.5% to INR 128.9 crores.
Achieved debt-free status in January 2026, down from a debt of INR 243 crores in September 2025.
Group market share increased to 32.2%, representing a 307 bps year-on-year improvement.
Technology revenues surged 81.5% YoY, with the MAven Guard platform preventing INR 400 crores in fraud.
Paramount integration is on track with a slump transfer of business effective February 1, 2026.
💼 Action for Investors
Investors should take note of the rapid deleveraging and successful integration of Paramount which is driving margin expansion. The strong growth in high-margin tech-led revenues and dominant market share in the group segment makes it a compelling play in the TPA space.
CARE Reaffirms Medi Assist Rating at 'AA-; Stable'; Company Repays Entire ₹150 Cr Bridge Debt
CARE Ratings has reaffirmed Medi Assist's long-term rating at 'CARE AA-; Stable', reflecting its dominant 21.3% market share in the TPA industry. The company has successfully repaid its entire ₹150 crore bridge debt used for the ₹412 crore Paramount TPA acquisition, returning to a net debt-free status as of January 2026. Financial performance remains strong with Premiums Under Management (PUM) expected to reach ₹26,500 crore in FY26, supported by a 94% corporate retention rate. While integration of new acquisitions slightly compressed H1FY26 margins to 19.3%, profitability is expected to recover to the 21-22% range in the medium term.
Key Highlights
CARE AA-; Stable and CARE A1+ ratings reaffirmed for bank facilities totaling ₹16 crore.
Successfully repaid ₹150 crore bridge debt by January 15, 2026, following a ₹198 crore preferential issue.
Market share in group insurance segment increased to 32.2% as of September 2025.
PUM projected to grow to ₹26,500 crore in FY26, up from ₹21,108 crore in FY25.
Maintains a robust network of over 20,000 hospitals and 10,500 corporate clients with 94% retention.
💼 Action for Investors
Investors should take confidence in the company's ability to fund large acquisitions (Paramount TPA) and quickly return to a debt-free status. The reaffirmation of high credit ratings and dominant market share positions the company well for long-term growth in the health insurance sector.
Medi Assist Credit Rating Reaffirmed at CARE AA-; Stable; Company Now Debt-Free
CARE Ratings has reaffirmed Medi Assist's credit rating at 'CARE AA-; Stable' for long-term and 'CARE A1+' for short-term facilities. The company has successfully integrated the ₹412 crore Paramount TPA acquisition and repaid its entire external debt of ₹150 crore as of January 2026. With a market share of 21.3% in the TPA industry, the company expects revenue growth of 27-28% in FY26. Despite a temporary dip in H1FY26 margins to 19.32%, synergy benefits are expected to restore margins to 21-22% in the medium term.
Key Highlights
CARE Ratings reaffirmed 'CARE AA-; Stable' and 'CARE A1+' ratings for bank facilities totaling ₹16 crore.
Company is now debt-free after repaying ₹150 crore bridge debt used for the Paramount TPA acquisition.
Market share in the overall health TPA industry rose to 21.3% following strategic acquisitions.
Revenue growth is projected at 27-28% for FY26, driven by higher Premiums Under Management (PUM).
Preferential issue of ₹198 crore in October 2025 significantly strengthened the balance sheet and liquidity.
💼 Action for Investors
The reaffirmation and debt-free status confirm strong financial management after a large acquisition. Investors should monitor the company's ability to maintain its 20%+ operating margins while scaling its market share.
Persistent Named Fastest Growing Global IT Services Brand; Brand Value Up 22% to $989M
Persistent Systems has been recognized as the fastest-growing IT services brand globally in the 2026 Brand Finance IT Services 25 report. The company's brand value increased by 22% year-on-year, rising from $811 million in 2025 to $989 million in 2026. This recognition is backed by 23 sequential quarters of revenue growth and a total brand value surge of 468% since 2020. The company now ranks as the 12th strongest IT services brand globally with an improved Brand Strength Index of 75.8.
Key Highlights
Brand value increased 22% year-on-year to $989 million in 2026.
Ranked as the 12th strongest IT Services brand globally with an AA+ rating.
Achieved 468% growth in brand value since 2020, the highest in its category.
Maintained 23 sequential quarters of revenue growth leading up to the recognition.
Brand Strength Index (BSI) improved from 74.8 to 75.8.
💼 Action for Investors
This recognition underscores Persistent's successful transition into a large-scale enterprise transformation partner and its growing competitive moat in AI-led services. Investors should monitor if this enhanced brand equity translates into higher win rates for large-scale digital engineering contracts.
Medi Assist Q3 FY26: Revenue Up 30%, Debt-Free Status Achieved, Paramount Integration on Track
Medi Assist reported a strong Q3 FY26 with consolidated revenue growing 29.9% YoY to ₹247.2 Cr, driven by the Paramount acquisition and organic growth. The company successfully transitioned to a debt-free status in January 2026 after significantly reducing debt from ₹243.4 Cr in September 2025. Operational efficiency improved with consolidated EBITDA margins expanding 154 bps QoQ to 18.6%, while Paramount's standalone margins saw a significant 557 bps QoQ jump. Market share in the group segment reached 32.2%, and technology-led revenue surged 81.5% YoY, highlighting the scalability of its AI-powered platform.
Key Highlights
Consolidated Total Income grew 29.9% YoY to ₹247.2 Cr in Q3 FY26.
Achieved debt-free status in January 2026, down from ₹243.4 Cr debt in September 2025.
Group market share expanded to 32.2%, with total premiums under management reaching ₹19,289.1 Cr.
Technology segment revenue grew 81.5% YoY; MAven Guard identified ~₹400 Cr in fraud savings.
Paramount TPA business slump transfer to Medi Assist TPA approved, effective February 1, 2026.
💼 Action for Investors
Investors should view the rapid debt reduction and margin expansion at Paramount as strong positive signals for future profitability. The stock remains a key play on the growing health insurance penetration in India through a scalable, tech-led TPA model.
Medi Assist Q3 FY26: 24% Revenue Growth, Becomes Debt-Free with 32.2% Group Market Share
Medi Assist reported a robust 24% YoY revenue growth for 9M FY26, driven by a 21.9% increase in premiums administered to INR 19,298.1 Cr. The company achieved a significant milestone by becoming debt-free in January 2026, supported by a healthy free cash balance of INR 200.1 Cr. Market share in the critical Group segment expanded by 307 bps to 32.2%, while technology-led revenues surged by 81.5% YoY. The integration of Paramount TPA is on track with the business transfer effective from February 1, 2026.
Key Highlights
Operating revenue grew 24% YoY for 9M FY26, with adjusted PAT reaching INR 46.3 Cr.
Company became debt-free from January 2026, reducing debt from INR 39.4 Cr in Dec '25.
Group market share expanded by 307 bps YoY to 32.2%, with total premiums reaching INR 19,298.1 Cr.
Technology-driven revenues grew 81.5% YoY, with AI-powered fraud detection flagging INR 400 Cr in potential fraud.
Paramount TPA integration finalized with business transfer effective Feb 1, 2026, and tech migration complete.
💼 Action for Investors
Investors should view the debt-free status and significant market share gains as strong indicators of operational efficiency and competitive dominance. The successful integration of Paramount TPA and surge in high-margin tech revenue suggest potential for further margin expansion.
Medi Assist Reports Zero Deviation in Utilization of ₹198 Cr Raised via Preferential Issue
Medi Assist Healthcare Services has confirmed zero deviation in the utilization of ₹198.00 crore raised through a preferential issue in October 2025. As of December 31, 2025, the company has successfully utilized ₹148.40 crore primarily for debt prepayment and repayment in its material subsidiary, Medi Assist Insurance TPA Pvt. Ltd. The remaining ₹49.60 crore is currently parked in liquid mutual funds and bank balances, intended for general corporate purposes. The monitoring agency, CARE Ratings, has verified the deployment and reported no concerns or variations from the original objects.
Key Highlights
Total funds raised via preferential issue amounted to ₹198.00 crore on October 10, 2025.
₹148.40 crore utilized for debt repayment in subsidiary, meeting 98.9% of the specific allocation for that object.
Zero deviation reported in the utilization of funds compared to the objects stated in the offer document.
Unutilized proceeds of ₹49.60 crore are safely deployed in liquid mutual funds across four major AMCs.
CARE Ratings Limited, acting as the Monitoring Agency, confirmed all utilizations align with the EGM resolution.
💼 Action for Investors
Investors should take confidence in the company's transparent capital allocation and adherence to stated timelines for debt reduction. The successful deployment of funds for subsidiary debt repayment is expected to strengthen the consolidated balance sheet.
Medi Assist to Integrate Paramount TPA via Slump Sale and Merger
Medi Assist Healthcare has approved a three-step integration plan for Paramount TPA, which it acquired in July 2025. The process involves a slump transfer of the TPA business to Medi Assist TPA effective February 1, 2026, followed by the surrender of Paramount's license and a final merger of the residual entity into the parent company. This restructuring is designed to comply with IRDAI regulations and achieve operational efficiencies by consolidating two licensed entities. Paramount TPA reported a standalone turnover of ₹1,785.70 million and a net worth of ₹993.46 million for FY25.
Key Highlights
Slump transfer of Paramount TPA's business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA recorded a turnover of ₹1,785.70 million and net worth of ₹993.46 million as of March 31, 2025.
Final merger of residual Paramount entity into the listed parent company with an appointed date of July 1, 2025.
Integration aims to achieve economies of scale and centralized treasury management of surplus funds.
No change in the shareholding pattern of the listed entity (Medi Assist Healthcare) post-merger.
💼 Action for Investors
Investors should view this as a positive move to simplify the corporate structure and realize synergies from the Paramount acquisition. Monitor the progress of the IRDAI license surrender and the final NCLT merger approval.
Medi Assist to Integrate Paramount TPA via Slump Sale and Merger
Medi Assist Healthcare Services is executing a three-step integration of Paramount TPA, which it acquired in July 2025. The process involves a slump transfer of the TPA business to its subsidiary, Medi Assist TPA, followed by the surrender of Paramount's license and a final merger of the residual entity into the parent company. This restructuring is designed to comply with IRDAI regulations and consolidate treasury assets under the listed parent entity. No new shares will be issued as Paramount is a wholly-owned step-down subsidiary, ensuring no equity dilution.
Key Highlights
Slump transfer of Paramount TPA business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA reported a standalone turnover of ₹1,785.70 million and net worth of ₹993.46 million as of March 31, 2025.
The merger appointed date is fixed as July 1, 2025, to facilitate consolidation of treasury and accounts.
Restructuring aims to achieve economies of scale and reduce administrative costs through a simplified corporate structure.
Integration fulfills IRDAI's condition to operate under a single TPA license post-acquisition.
💼 Action for Investors
Investors should view this as a positive move toward operational synergy and regulatory compliance. The consolidation of treasury assets at the parent level enhances corporate governance and capital allocation efficiency.
Medi Assist to Restructure Paramount TPA via Slump Sale and Merger for Operational Efficiency
Medi Assist Healthcare Services has approved a three-step integration plan for Paramount TPA, a subsidiary acquired in July 2025. The plan involves a slump transfer of the TPA business to Medi Assist TPA for nil consideration, followed by the surrender of Paramount's regulatory license. Finally, the residual entity, which holds treasury assets and reported an FY25 standalone turnover of ₹1,785.70 million, will be merged into the listed parent company to centralize capital management.
Key Highlights
Slump transfer of Paramount TPA's business to Medi Assist TPA effective February 1, 2026, for nil consideration.
Paramount TPA reported a standalone turnover of ₹1,785.70 million and net worth of ₹993.46 million for FY25.
The merger of the residual entity into the parent company has an appointed date of July 1, 2025, for consolidation purposes.
Restructuring fulfills IRDAI mandates to integrate licensed TPA businesses post-acquisition into a single entity.
No change in the shareholding pattern of the listed entity as the target is a wholly-owned step-down subsidiary.
💼 Action for Investors
Investors should view this as a positive move to simplify corporate structure and reduce administrative overheads. The consolidation of treasury assets at the parent level should improve capital allocation and corporate governance.